2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
34
Breast
32
Thoracic
12
Other
12
Lymphoid
10
Genitourinary
8
Other hematologic neoplasm
6
Gynecologic
6
CNS
6
Endocrine
4
Dermatologic
4
Classical hematology
3
Sarcoma
2
Plasma cell
2
Myeloid
2
Head & Neck
1
Conditions
Myelodysplastic Syndromes
1478
Leukemia, Myeloid, Acute
1239
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
863
Leukemia
745
Precursor Cell Lymphoblastic Leukemia-Lymphoma
704
Myeloproliferative Disorders
631
Leukemia, Myelomonocytic, Chronic
455
Lymphoma, Non-Hodgkin
447
Primary Myelofibrosis
430
Multiple Myeloma
423
Leukemia, Lymphocytic, Chronic, B-Cell
408
Hodgkin Disease
384
Lymphoma
343
Leukemia, Myeloid, Chronic-Phase
335
Blast Crisis
282
Polycythemia Vera
267
Leukemia, Myeloid, Accelerated Phase
263
Lymphoma, Follicular
254
Lymphoma, Mantle-Cell
253
Burkitt Lymphoma
246
Lymphoma, Large B-Cell, Diffuse
244
Lymphoma, B-Cell, Marginal Zone
225
Congenital Abnormalities
215
Lymphoma, Large-Cell, Immunoblastic
201
Myelodysplastic-Myeloproliferative Diseases
199
Thrombocythemia, Essential
197
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
196
Anemia, Refractory, with Excess of Blasts
194
Hematologic Neoplasms
193
Neoplasms, Plasma Cell
184
Interventions
Diet, Mediterranean
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Inflammation
×
Myeloid
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled